![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
Europe
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
68
PharmaCompass offers a list of Technivie API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Technivie manufacturer or Technivie supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Technivie manufacturer or Technivie supplier.
PharmaCompass also assists you with knowing the Technivie API Price utilized in the formulation of products. Technivie API Price is not always fixed or binding as the Technivie Price is obtained through a variety of data sources. The Technivie Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ombitasvir / paritaprevir / ritonavir manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ombitasvir / paritaprevir / ritonavir, including repackagers and relabelers. The FDA regulates Ombitasvir / paritaprevir / ritonavir manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ombitasvir / paritaprevir / ritonavir API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ombitasvir / paritaprevir / ritonavir supplier is an individual or a company that provides Ombitasvir / paritaprevir / ritonavir active pharmaceutical ingredient (API) or Ombitasvir / paritaprevir / ritonavir finished formulations upon request. The Ombitasvir / paritaprevir / ritonavir suppliers may include Ombitasvir / paritaprevir / ritonavir API manufacturers, exporters, distributors and traders.
Ombitasvir / paritaprevir / ritonavir Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ombitasvir / paritaprevir / ritonavir GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ombitasvir / paritaprevir / ritonavir GMP manufacturer or Ombitasvir / paritaprevir / ritonavir GMP API supplier for your needs.
A Ombitasvir / paritaprevir / ritonavir CoA (Certificate of Analysis) is a formal document that attests to Ombitasvir / paritaprevir / ritonavir's compliance with Ombitasvir / paritaprevir / ritonavir specifications and serves as a tool for batch-level quality control.
Ombitasvir / paritaprevir / ritonavir CoA mostly includes findings from lab analyses of a specific batch. For each Ombitasvir / paritaprevir / ritonavir CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ombitasvir / paritaprevir / ritonavir may be tested according to a variety of international standards, such as European Pharmacopoeia (Ombitasvir / paritaprevir / ritonavir EP), Ombitasvir / paritaprevir / ritonavir JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ombitasvir / paritaprevir / ritonavir USP).